A global pharmaceutical company (1)
Our client was looking to market two new generic medicines – one for Parkinson’s Disease and one for cancer. To enable marketing to begin, we had first to file EPO oppositions against two key patents held by competitors before assisting in the resulting litigation that arose in the UK and The Netherlands.
For the Parkinson’s Disease drug, we provided an initial invalidity opinion that went on to form the framework for the revocation actions we launched in both countries. In the UK, our partner Richard Cooke successfully provided evidence on the timings of EPO opposition proceedings which persuaded the High Court judge to find in our client’s favour. For the cancer drug we provided an opinion that formed the basis for our client’s successful non-infringement action. High-value pharmaceutical UK litigation work is a significant part of our practice. As a result, our attorneys not only find themselves closely involved in litigation proceedings but also giving evidence in patent proceedings before the High Court; a level very few patent attorneys operate at.
For further details of this type of work, contact Dr Richard Cooke.